Vyome Holdings HIND
NASDAQ HIND
$1.91 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vyome Holdings (HIND) Selling, General & Administrative (2015 - 2026)

Updated

Vyome Holdings' Selling, General & Administrative was $364,891 in Q2 2026, up 37.5% from $265,395 a year earlier but down 23.6% from the prior quarter.

Analysis

Vyome Holdings (HIND) Selling, General & Administrative (2015 - 2026) Analysis & Trends

On a trailing twelve-month basis, Vyome Holdings' Selling, General & Administrative was $2.68 million through Jun 30, 2026, up 163.2% year-over-year; for FY2025, it came in at $2.37 million, up 163.3% from FY2024.

  • Selling, General & Administrative shows a five-year compound annual growth rate of -25.8% (FY2020 to FY2025).
  • In earlier years, Selling, General & Administrative was $898,572 in FY2024 (-91.3%), $10.32 million in FY2023 (-40.2%), $17.25 million in FY2022 (-29.1%) and $24.32 million in FY2021 (+131.0%).
  • Quarterly Selling, General & Administrative has moved between $246,821 (Q3 2024) and $11.88 million (Q3 2021) over five years.
  • Compared with a year earlier, Selling, General & Administrative has increased for four straight quarters, with growth averaging 40.2% over the last eight quarters.
  • The best year-over-year quarter for Selling, General & Administrative over five years was Q3 2021 (growth of 388.2%); the worst was Q3 2024 (a decline of 88.0%).
  • Per Business Quant data, HIND's Selling, General & Administrative in the three quarters before Q2 2026 was $477,575 (Q1 2026), $996,200 (Q4 2025) and $844,344 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Vyome Holdings 13.41 Mn -12.70 Mn 11,658.00 364,891.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 364,891.00
Mar 31, 2026 477,575.00
Dec 31, 2025 996,200.00
Sep 30, 2025 844,344.00
Jun 30, 2025 265,395.00
Mar 31, 2025 259,626.00
Dec 31, 2024 247,376.00
Sep 30, 2024 246,821.00
Jun 30, 2024 1.91 Mn
Mar 31, 2024 1.87 Mn
Dec 31, 2023 1.60 Mn
Sep 30, 2023 2.06 Mn
Jun 30, 2023 2.45 Mn
Mar 31, 2023 4.22 Mn
Dec 31, 2022 4.21 Mn
Sep 30, 2022 3.78 Mn
Jun 30, 2022 5.36 Mn
Mar 31, 2022 4.69 Mn
Dec 31, 2021 5.42 Mn
Sep 30, 2021 11.88 Mn
API Access

Vyome Holdings Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=HIND&period=max&api_key=YOUR_API_KEY